Status:
COMPLETED
Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Advocates
Conditions:
Intellectual Disability
Developmental Disability
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings is a research study aimed at developing, impleme...
Detailed Description
Persons with Serious Mental Illness (SMI) and Intellectual Disabilities and Developmental Disabilities (ID/DD) are disproportionately vulnerable to COVID-19 for three reasons: (1) Medical vulnerabilit...
Eligibility Criteria
Inclusion
- All congregate care homes in Massachusetts operated by the following public-sector community-based human service organizations: Vinfen, Bay Cove, Advocates, North Suffolk, Open Sky, and Riverside
- The group home must serve adults with SMI (Serious Mental Illness, i.e., DSM-V Diagnosis of Axis-I Mental Illness with persistent functional impairment) or adults with ID/DD (Intellectual and Developmental Disabilities)
- All residents and staff of the home must be age 18 or older
Exclusion
- 1\. All congregate care homes in Massachusetts not operated by any of the public-sector community-based human service organizations mentioned above
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
415 Patients enrolled
Trial Details
Trial ID
NCT04726371
Start Date
November 1 2020
End Date
November 30 2022
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114